Abstract
Direct-acting antivirals (DAAs) can now cure almost all patients with chronic hepatitis C. This gives us the opportunity to eliminate hepatitis C from Australia. However, the number of people receiving DAA treatment is declining despite an estimated 165,000 people living with chronic hepatitis C. GPs have a key role in identifying and treating their patients living with hepatitis C if we are to reduce disease burden and achieve hepatitis C elimination.
Original language | English |
---|---|
Pages (from-to) | 34-40 |
Number of pages | 7 |
Journal | Medicine Today |
Volume | 20 |
Issue number | 6 |
Publication status | Published - 2019 |